<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04770025</url>
  </required_header>
  <id_info>
    <org_study_id>20-010</org_study_id>
    <secondary_id>P30GM122734</secondary_id>
    <nct_id>NCT04770025</nct_id>
  </id_info>
  <brief_title>A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol</brief_title>
  <acronym>tACS-MI</acronym>
  <official_title>Transcranial Alternating Current Stimulation to Boost the Efficacy of Motivational Interviewing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Mind Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of General Medical Sciences (NIGMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The Mind Research Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this small (n=75) proof-of-concept randomized clinical trial is to test the&#xD;
      effects of transcranial alternating current stimulation (tACS) during motivational&#xD;
      interviewing (MI) sessions with participants who drink at above the low-risk level.&#xD;
      Participants will be randomized to receive either MI with active stimulation, MI with sham&#xD;
      stimulation, or a delayed treatment group that receives MI with no stimulation. Measures will&#xD;
      include brain imaging, alcohol use, cannabis use, risk-taking behavior, emotions, and others.&#xD;
      Participants who are randomized to the delayed-treatment group will not receive brain&#xD;
      imaging.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This proof-of-concept randomized clinical trial will recruit n=75 people with problematic&#xD;
      levels of drinking who are considering treatment for their alcohol use. These participants&#xD;
      will be randomized to one of three conditions: a condition that applies active tACS during an&#xD;
      MI session (MI+tACS), a condition that applies sham stimulation during an MI session&#xD;
      (MI+sham), or a waitlist control condition (MI-only). Only participants the MI+tACS and&#xD;
      MI+sham conditions will be included in the brain imaging portion of the study. One month&#xD;
      after their intervention session, all participants will report their use of alcohol in the&#xD;
      prior 30 days via an online assessment battery. This will allow us to test the effects of&#xD;
      tACS on within-session client speech and outcomes.&#xD;
&#xD;
      Participants will have magnetoencephalography (MEG) scans including rest and an alcohol cue&#xD;
      task to measure the acute effects of brain stimulation. Participants will also have MRI scans&#xD;
      including structure and rest. The Motivational Interviewing Skill Code (MISC 2.5) and the&#xD;
      CASAA Application for Coding Treatment Interactions (CACTI) will be used to assess counselor&#xD;
      and participant speech in the recorded MI sessions and to ensure that sessions comply with&#xD;
      the principles of MI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Double-blind proof-of-concept randomized clinical trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Double (Participant, Providers/Research Assistants)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Heavy drinking days</measure>
    <time_frame>One month</time_frame>
    <description>Number of heavy drinking days in the prior 30 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Drinks per drinking day</measure>
    <time_frame>One month</time_frame>
    <description>Number of drinks per drink day in the prior 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent days abstinent</measure>
    <time_frame>One month</time_frame>
    <description>Percent days abstinent in the prior 30 days</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Alcohol Use Disorder</condition>
  <arm_group>
    <arm_group_label>MI with tACS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Motivational interviewing with concurrent active stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MI with sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Motivational interviewing with concurrent sham stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MI-only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Motivational interviewing only, delayed treatment control</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High-density transcranial alternating current stimulation</intervention_name>
    <description>High-density electrode configuration with transcranial alternating current stimulation in the beta (15-40Hz) frequency range</description>
    <arm_group_label>MI with tACS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham stimulation</intervention_name>
    <description>High-density electrode configuration with sham stimulation</description>
    <arm_group_label>MI with sham</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational interviewing</intervention_name>
    <description>Motivational interviewing session focused on alcohol use, approximately 30 minutes in length</description>
    <arm_group_label>MI with sham</arm_group_label>
    <arm_group_label>MI with tACS</arm_group_label>
    <arm_group_label>MI-only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Self-identify as having problem drinking&#xD;
&#xD;
          -  Right-handed&#xD;
&#xD;
          -  Age 21-60 years&#xD;
&#xD;
          -  AUDIT score indicating risky drinking&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Left-handed or ambidextrous&#xD;
&#xD;
          -  Currently engaged in treatment for alcohol use disorder&#xD;
&#xD;
          -  Receiving treatment for alcohol use disorder within the prior 12 months&#xD;
&#xD;
          -  History of brain injury or neurological diagnosis&#xD;
&#xD;
          -  Evidence of current psychosis&#xD;
&#xD;
          -  Past-year substance use disorder other than alcohol, marijuana, or nicotine&#xD;
&#xD;
          -  Current or history of severe alcohol withdrawal&#xD;
&#xD;
          -  MRI/tACS contraindications including pregnancy&#xD;
&#xD;
          -  Impaired hearing (psychotherapy using American Sign Language is not possible within&#xD;
             the scope of the proposed study)&#xD;
&#xD;
          -  Insufficient corrected visual acuity to complete the assessment instruments&#xD;
&#xD;
          -  Unable to read/speak English fluently&#xD;
&#xD;
          -  Unable to provide valid informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jon M Houck, PhD</last_name>
    <phone>(505) 925-2372</phone>
    <email>brainstim@mrn.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Mind Research Network</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jon M Houck, PhD</last_name>
      <phone>505-925-2372</phone>
      <email>brainstim@mrn.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 22, 2021</study_first_submitted>
  <study_first_submitted_qc>February 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2021</study_first_posted>
  <last_update_submitted>March 1, 2021</last_update_submitted>
  <last_update_submitted_qc>March 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alcohol Use Disorder</keyword>
  <keyword>Motivational Interviewing</keyword>
  <keyword>Transcranial Electrical Stimulation</keyword>
  <keyword>Alcohol Drinking</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie results reported in a peer-reviewed publication, after deidentification (text, tables, figures, and appendices). Session audio recordings will not be shared.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Beginning 3 months and ending 5 years following article publication.</ipd_time_frame>
    <ipd_access_criteria>Researchers who provide a methodologically sound proposal will have access to the data. A data use agreement will be required, signed by the requesting investigator and their Authorized Organization Representative (AOR)/Signing Official (SO)</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form: Informed Consent</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 20, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT04770025/ICF_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form: Informed Consent - Phase I online-only</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 20, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT04770025/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

